COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 2546: Articles 25451-25460  | Next

Forecasting COVID-19 Dynamics and Endpoint in Bangladesh: A Data-driven Approach
Hridoy, A.-E. E., Naim, M., Emon, N. U., Tipo, I. H., Alam, S., Al Mamun, A., Islam, M. S.
10.1101/2020.06.26.20140905 — Posted: 2020-06-28
Cost Benefit Analysis of Limited Reopening Relative to a Herd Immunity Strategy or Shelter in Place for SARS-CoV-2 in the United States
Schonberger, R. B., Listokin, Y. J., Ayres, I., Yaesoubi, R., Shelley, Z. R.
10.1101/2020.06.26.20141044 — Posted: 2020-06-28
Social media and smartphone app use predicts maintenance of physical activity during Covid-19 enforced isolation in psychiatric outpatients
Norbury, A., Liu, S. H., Campana-Montes, J. J., Romero-Medrano, L., Barrigon, M. L., Smith, E., MEmind Study Group, , Artes, A., Baca-Garcia, E., Perez-Rodriguez, M. M.
10.1101/2020.06.26.20141150 — Posted: 2020-06-28
Memory-Dependent Model for the Dynamics of COVID-19 Pandemic
Furati, K. M., Sarumi, I. O., Khaliq, A. Q. M.
10.1101/2020.06.26.20141242 — Posted: 2020-06-28
Binding Ability Prediction between Spike Protein and Human ACE2 Reveals the Adaptive Strategy of SARS-CoV-2 in Humans
Xue, X., Shi, J., Xu, H., Qin, Y., Yang, Z., Feng, S., Liu, D., Jian, L., Hua, L., Wang, Y., Zhang, Q., Huang, X., Zhang, X., Li, X., Chen, C., Guo, J., Tang, W., Liu, J.
10.1101/2020.06.25.170704 — Posted: 2020-06-27
Critical Sequence Hot-spots for Binding of nCOV-2019 to ACE2 as Evaluated by Molecular Simulations
Ghorbani, M., Brooks, B. R., Klauda, J. B.
10.1101/2020.06.27.175448 — Posted: 2020-06-27
Structures, conformations and distributions of SARS-CoV-2 spike protein trimers on intact virions
Ke, Z., Oton, J., Qu, K., Cortese, M., Zila, V., McKeane, L., Nakane, T., Zivanov, J., Neufeldt, C. J., Lu, J. M., Peukes, J., Xiong, X., Krausslich, H.-G., Scheres, S. H. W., Bartenschlager, R., Briggs, J. A. G.
10.1101/2020.06.27.174979 — Posted: 2020-06-27
Modified Vaccinia Ankara Based SARS-CoV-2 Vaccine Expressing Full-Length Spike Induces Strong Neutralizing Antibody Response
Routhu, N. K., Gangadhara, S., Cheedarla, N., Shiferaw, A., Rahman, S. A., Sahoo, A., Shi, P.-Y., Menachery, V. D., Floyd, K., Fischinger, S., Atyeo, C., Alter, G., Suthar, M. S., Amara, R. R.
10.1101/2020.06.27.175166 — Posted: 2020-06-27
Saliva sampling is an excellent option to increase the number of SARS CoV2 diagnostic tests in settings with supplies shortages
Moreno-Contreras, J., Espinoza, M. A., Sandoval-Jaime, C., Cantu-Cuevas, M. A., Baron-Olivares, H., Ortiz-Orozco, O., Munoz-Rangel, V. A., Hernandez-de Jesus, M., Eroza-Osorio, C. M., Arias, C. F., Lopez, S.
10.1101/2020.06.24.170324 — Posted: 2020-06-27
Glycans on the SARS-CoV-2 Spike Control the Receptor Binding Domain Conformation
Henderson, R., Edwards, R. J., Mansouri, K., Janowska, K., Stalls, V., Kopp, M., Haynes, B. F., Acharya, P.
10.1101/2020.06.26.173765 — Posted: 2020-06-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).